Malin chief sees demand for 23% Woodford stake
New CEO says company will have enough investor demand to absorb the holding if sold
New CEO says company will have enough investor demand to absorb the holding if sold
Value of portfolio fell 5% in first half of the year
Four main assets on track to reach ‘important milestones’
Seen and heard: Nama to sell John Player site as Marlet to build 1,000 units in Tallaght
Plus, good times return for top AIB clients
Almost 51% vote against plan at health firm’s agm over director remuneration concerns
Company says it will focus on core assets, which account for more than 70% of portfolio
Series of investments in life science companies have been badly received by the market
Seen & Heard: BAI ‘had delayed’ Xavier Niel’s takeover of Eir over concerns
Life sciences group targeting 15% growth in the total value of its investee portfolio in 2018
Artizan aims to be a leader in the microbiota-driven inflammatory diseases space
Malin’s chief investment officer received relocation payment of €393,000 last year
Irish-listed Malin to take a 31 per cent stake in US-based human therapeutics firm
Irish-based firm joins in Europe’s largest Series A life science financing
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices